Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the study record rather than a substantive change to its content.
    Difference
    0.1%
    Check dated 2026-05-18T13:17:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new citation for a 2026 Eur J Cancer article is added to the Publications section about pembrolizumab in CUP, and the previous 'Online ahead of print' citation is removed.
    Difference
    0.1%
    Check dated 2026-05-11T11:37:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now indicates that results have been submitted (instead of none posted) and reflects a newer interface/site revision version.
    Difference
    0.1%
    Check dated 2026-04-27T07:30:48.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Publications section added featuring a related PubMed citation. It also notes that publications are auto-filled from PubMed and may not all pertain to the study.
    Difference
    0.3%
    Check dated 2026-04-13T01:11:45.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T08:44:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T19:29:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.